Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications

Ann Oncol. 2012 Jan;23(1):280-1. doi: 10.1093/annonc/mdr525. Epub 2011 Nov 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzenesulfonates / adverse effects*
  • Fibroblast Growth Factors / metabolism*
  • Humans
  • Hypophosphatemia / chemically induced*
  • Hypophosphatemia / metabolism*
  • Male
  • Pyridines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Pyridines
  • Fibroblast Growth Factors